30 participants
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-08-10
- Completion:
- 2028-08-10
Conditions
- Allergic Reaction (IgA) Vasculitis
Interventions
- DRUG
No Results Yet